Astragalus polysaccharide alleviates cognitive impairment and β-amyloid accumulation in APP/PS1 mice via Nrf2 pathway

Xiude Qin,Jun Hua,Song-Jun Lin,Hao-Tao Zheng,Jian-Jun Wang,Wei Li,Jin-Ju Ke,Hao-Bin Cai,Song-jun Lin,Hao-tao Zheng,Jian-jun Wang,Jin-ju Ke,Hao-bin Cai

DOI: https://doi.org/10.1016/j.bbrc.2020.07.122

IF: 3.1

2020-10-01

Biochemical and Biophysical Research Communications

Abstract:<p>Alzheimer's disease (AD) is the most common neurodegenerative disorder, and its etiology and pathogenesis are not fully understood. Astragalus polysaccharide (APS) has many pharmacological activities, but there are few reports about its role in AD. Using the common AD model APP/PS1 mice, it was found that the expression of Keap1 (a negative regulatory factor of Nrf2), the protein level of cytoplasmic Nrf2 and the content of MDA were increased significantly, while the mRNA level of Nrf2, the expression of Nrf2 in nucleus and the contents of SOD and GSH-Px were decreased significantly. APS treatment significantly increased the expression of Nrf2 in the nucleus but decreased its expression in the cytoplasm, and restored the expression levels of Keap1, SOD, GSH-Px and MDA. When APP/PS1 mice were treated with APS and injected with Nrf2 siRNA, the down-regulation of Nrf2 expression significantly blocked the regulation of APS on oxidative stress. Continuing to test the physiological function of AD mice showed that the spatial learning and memory abilities of APP/PS1 mice were impaired, the apoptosis of brain cells and the content of β-amyloid (Aβ) were significantly increased. APS treatment significantly improved the cognitive ability of APP/PS1 mice, reduced apoptosis and the accumulation of Aβ, but the above effects of APS were blocked by Nrf2 siRNA injection. Therefore, APS can activate Nrf2 pathway to improve the physiological function of AD mice, which may have important clinical application value.</p>

biochemistry & molecular biology,biophysics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: whether Astragalus polysaccharide (APS) can improve cognitive impairment and β - amyloid (Aβ) accumulation in Alzheimer's disease (AD) mouse models by activating the Nrf2 signaling pathway. Specifically, the research mainly focuses on the following points: 1. **Regulation of the Nrf2 Signaling Pathway**: - Nrf2 is an important antioxidant transcription factor. By regulating the expression of multiple downstream antioxidant enzyme genes, it exerts neuroprotective effects such as antioxidant and anti - inflammatory effects. In the pathological process of AD, the activity of the Nrf2 signaling pathway usually decreases. - The research aims to verify whether APS can restore the impaired antioxidant capacity in AD mouse models and reduce oxidative stress damage by activating the Nrf2 signaling pathway. 2. **Improvement of Cognitive Function**: - Through behavioral tests such as the Morris water maze experiment, the impact of APS on the cognitive function of AD mice is evaluated. - The research has found that APS can significantly improve the spatial learning and memory abilities of APP/PS1 mice, reduce neuronal apoptosis, and thus relieve cognitive impairment. 3. **Reduction of Aβ Accumulation**: - Abnormal deposition of Aβ is one of the important pathological features of AD. In particular, the deposition of Aβ42 is considered a key factor in inducing and promoting the development of AD pathology. - Research shows that after APS treatment, the contents of Aβ40 and Aβ42 in the brains of AD mice are significantly reduced, which may be related to the activation of the Nrf2 signaling pathway. 4. **Mechanism Verification**: - To further confirm the mechanism of action of APS, the research uses Nrf2 siRNA injection to block the expression of Nrf2. The results show that Nrf2 siRNA significantly inhibits the regulatory effects of APS on oxidative stress, neuronal apoptosis, and Aβ accumulation, proving that the protective effect of APS does indeed depend on the activation of the Nrf2 signaling pathway. In summary, the main purpose of this research is to explore the possibility that APS can reduce oxidative stress, decrease Aβ accumulation, and improve cognitive function in AD mouse models by activating the Nrf2 signaling pathway, providing a theoretical basis for the development of new drugs for AD treatment.

Astragalus polysaccharide alleviates cognitive impairment and β-amyloid accumulation in APP/PS1 mice via Nrf2 pathway

Astragalin Ameliorates Cognitive Dysfunction Through Inhibiting PI3K/Akt-MTOR-Mediated Autophagic Flow in Hippocampal Neurons of APP/PS1 Mice

NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice

Anti-Apoptosis Effect of Astragaloside Iv on Alzheimer's Disease Rat Model Via Enhancing the Expression of Bcl-2 and Bcl-Xl

Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus

Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment

EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways

Astragalin improves cognitive disorder in Alzheimer's disease: Based on network pharmacology and molecular docking simulation

20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis

Artemisia annua Extract Improves the Cognitive Deficits and Reverses the Pathological Changes of Alzheimer's Disease via Regulating YAP Signaling

Polysaccharide from Polygala tenuifolia alleviates cognitive decline in Alzheimer's disease mice by alleviating Aβ damage and targeting the ERK pathway

Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

Polysaccharides from Lycium Barbarum Ameliorate Amyloid Pathology and Cognitive Functions in APP/PS1 Transgenic Mice.

Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice

Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases

Astaxanthin attenuates cognitive deficits in Alzheimer's disease models by reducing oxidative stress via the SIRT1/PGC-1α signaling pathway

Long-term oral administration of hyperoside ameliorates AD-related neuropathology and improves cognitive impairment in APP/PS1 transgenic mice

Electroacupuncture Improves Learning and Memory Abilities via Activating AMPK/mTOR-Induced Autophagy in APP/PS1 Mice

Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease

Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model